Filed revenue acceleration
Active · now 61.0%TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.
Close 11/16
From Rhythm Pharmaceuticals, Inc. to every stock like it
AI finds several complementary traits of Rhythm Pharmaceuticals, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.
Screen stocks like Rhythm Pharmaceuticals, Inc.Growth: Good, Momentum: Good, Risk / liquidity: Good; Valuation: Pricey, Quality: Weak.
Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.
This page refreshes daily after the close. Add Rhythm Pharmaceuticals, Inc. to your watchlist to track signal changes on your next visit.
Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.
TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.
Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.
Average forward return after EPS surprise beat
20-day: Win 42.9%, Sample 14, Median -6.0%, Excess -1.5%, Beat mkt rate 50.0%
60-day: Win 42.9%, Sample 14, Median -5.7%, Excess -9.0%, Beat mkt rate 50.0%
120-day: Win 46.2%, Sample 13, Median -0.4%, Excess +6.0%, Beat mkt rate 46.2%
120 days after: historical avg +13.2%
Over 13 occurrences, 120-day forward avg gained 13.2%, beat the market by 6.0 pts; win rate 46.2%.
Across 101,149 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.29%, a 58.4% positive-return rate, and +2.96 percentage points of average excess return versus the S&P 500.
Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).
Inactive signals still show the stock-specific historical forward-return distribution for context.
Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.
16 times historically; 60-day forward avg -0.8%, win rate 50.0%, beating the market by -4.7 pts on average.
The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.
19 times historically; 60-day forward avg +15.8%, win rate 66.7%, beating the market by +10.4 pts on average.
This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.